Corrado Advisors’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Corrado Advisors’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,004	Closed	-$62K	–	107
2018 Q3	$62K	Sell	1,004 -6,891	-87%	-$466K	0.04%	98
2018 Q2	$582K	Buy	7,895 +323	+4%	+$25.2K	0.35%	55
2018 Q1	$497K	Buy	7,572 +249	+3%	+$18.8K	0.3%	57
2017 Q4	$616K	Sell	7,323 -1,484	-17%	-$146K	0.36%	54
2017 Q3	$1.02M	Buy	8,807 +507	+6%	+$53.3K	0.57%	48
2017 Q2	$969K	Sell	8,300 -62	-0.7%	-$7.7K	0.53%	47
2017 Q1	$1.03M	Buy	+8,362	New	+$1.1M	0.59%	46
2015 Q3	–	Sell	-1,705	Closed	-$363K	–	86
2015 Q2	$363K	Buy	1,705 +10	+0.6%	+$2.45K	0.16%	69
2015 Q1	$393K	Buy	+1,695	New	+$410K	0.17%	62

Other funds holding BLCM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Corrado Advisors's BLCM Position: Q4 2018 in Review

Corrado Advisors sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q4 2018, closing a stake of 1,004 shares — an estimated $62K sold.

Corrado Advisors first reported a position in BLCM in Q1 2015 and held it in 9 quarters. The position peaked at $1.03M in Q1 2017. 92 funds tracked by Wall St. Rank hold BLCM as of Q4 2018.

Corrado Advisors reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
Corrado Advisors sold 1,004 Bellicum Pharmaceuticals, Inc. shares in Q4 2018, an estimated $62K.
Corrado Advisors first reported a position in Bellicum Pharmaceuticals, Inc. in Q1 2015 and held it in 9 quarters.
Corrado Advisors's Bellicum Pharmaceuticals, Inc. position peaked at $1.03M in Q1 2017.
92 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q4 2018.

Based on Corrado Advisors's 13F filing for Q4 2018, filed 9 Jan 2019.